Miss Anna Kamocka

Sub-specialties: General Surgery, Upper GI Surgery, Metabolic and Obesity Surgery.

02036532009

Overview

Miss Anna Kamocka is a Consultant Bariatric, Upper Gastrointestinal and General Surgeon and Upper GI Endoscopist at Welbeck Digestive Health. She is also Service Director for Bariatric and Upper GI Surgery at Chelsea and Westminster Hospital.

About Miss Anna Kamocka

Miss Anna Kamocka is a Consultant Bariatric, Upper Gastrointestinal, and General Surgeon with a specialist focus on minimally invasive surgery. She is the Service Director for Bariatric and Upper GI Surgery at Chelsea and Westminster Hospital. Her expertise includes the management of obesity and type 2 diabetes through laparoscopic primary and revisional bariatric surgery, as well as gallbladder surgery, laparoscopic and open hernia repairs, surgical treatment of reflux disease and achalasia, benign soft tissue lesions, and a wide range of other general surgical conditions.

Miss Kamocka trained at some of the UK’s most prestigious institutions, including Imperial College London, John Radcliffe Hospital in Oxford, St George’s Hospital in London, and the Royal Surrey County Hospital in Guildford. She went on to complete high-volume bariatric fellowships in Bruges, Belgium, and Rochester, New York. On her return from the U.S. in 2022, she was appointed Consultant Surgeon at Chelsea and Westminster Hospital NHS Foundation Trust.

Committed to advancing clinical standards through research and education, Miss Kamocka was awarded a PhD from Imperial College London for her work on bariatric surgery and diabetes remission. She also holds a Master’s in Surgical Education (MEd) and is a respected trainer, serving as Surgical Simulation Lead at Chelsea and Westminster Hospital. In addition, she mentors international doctors through the Clinical Attachment Training Programme. With numerous publications and contributions to book chapters, Miss Kamocka is widely recognised in her field and is regularly invited to speak at national and international conferences.

Areas of Expertise

Miss Anna Kamocka commonly treats:

Obesity
Gallstones
Hernia
Reflux
Achalasia
Pancreatitis
Appendicitis
Obesity and Women’s Health

She offers the following tests and treatments:

Laparoscopic Cholecystectomy
Hernia Surgery
Bariatric Surgery
Gastric Bypass
Sleeve Gastrectomy
Surgical Management of Type 2 Diabetes
Revisional Bariatric Surgery
Anti-reflux Surgery
Achalasia Surgery
Laparoscopic (Keyhole) Surgery
General Surgery

Additional Information

Miss Kamocka holds the following qualifications: PhD MEd. FRCS

She is an active member of:

Fellow of the Royal College of Surgeons
AUGIS (Association of Upper Gastrointestinal Surgery of Great Britain and Ireland)
BOMSS (British Obesity and Metabolic Surgery Society)
ASO (Association for the Study of Obesity)

She currently holds clinical posts at:

Consultant Bariatric, Upper Gastrointestinal and General Surgeon at Welbeck Digestive Health
Chelsea and Westminster Hospital (NHS and private)
The Lister Hospital
Service Director for Bariatric and Upper GI Surgery at Chelsea and Westminster Hospital

Miss Kamocka is the recipient of the following professional awards:

Royal College of Surgeons Research Fellow, 2018 – 2019
Foster-Schauer Award, Obesity Week, Las Vegas, 2019
PhD Travel Award, Imperial College London, 2017
Scholarship for Bariatric Mini-Fellowship with Dr Bruno Dillemans,
AZ Sint-Jan Hospital, Bruges, Belgium, 2015

Research Highlights

Miss Kamocka has published widely in peer-reviewed journals, written book chapters on obesity and metabolic surgery and is a reviewer for the Obesity Surgery journal. A few examples of her publications include:

Outcomes of bariatric surgery in extreme obesity: results from the United Kingdom National Bariatric Surgery Registry for patients with a body mass index >70kg/m2
SOARD 2021 Oct;17(10):1732-1738
Length of biliopancreatic limb in Roux-en-Y gastric bypass and its impact on post-operative outcomes in metabolic and obesity surgery-systematic review and meta-analysis.
Int J Obes 2022 Nov;46(11):1983-1991
The effect of standard versus longer intestinal bypass on GLP-1 regulation and glucose metabolism in patients with type 2 diabetes undergoing Roux-en-Y gastric bypass: The Long-Limb Study.
Diab Care 2021 May;44(5): 1082-1090
Liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019 Jul;7(7):549-559
Obesity surgery makes patients healthier and more functional - real world results from the United Kingdom National Bariatric Surgery Registry. Surg Obes Relat Dis., 2018 Jul;14(7):1033-
1040

Reviews

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.